跳至主要内容
临床试验/ISRCTN92184014
ISRCTN92184014已完成未知

Crossover trial of intranasal oxytocin for treating mother-infant attachment problems in postnatal depression

HS Greater Glasgow & Clyde (UK)0 个研究点目标入组 10 人开始时间: 2012年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Mother with history of low mood (recorded Edinburgh Postnatal Depression Score of ten or greater) with baby aged 8-16 weeks
  • 2. Mother aged 18 ? 50 years

排除标准

  • 1. Baby born before 38 weeks
  • 2. Significant obstetric complications
  • 3. Significant medical condition of mother or baby
  • 4. Substantial neurological or visual impairment of mother or baby
  • 5. Mother non-English speaking
  • 6. Mother continuing to breast feed
  • 7. Mother has physical condition which might affect nasal drug absorption (eg. URTI)
  • 8. Mother responsible for care of another child at time of home visit
  • 9. Mother pregnant
  • 10. Mothers on antidepressant medication will not be excluded from the study; however we will record if a subject is on medication

研究者

发起方
HS Greater Glasgow & Clyde (UK)

相似试验